Akebia Ther
Price & Volume
Stats
See more52W Range | $1.14-$4.07 |
Market Cap | $417.8M |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $236.1M |
Revenue Growth (YoY) | 23.9% |
Gross Profit (12 Mos) | $195.8M |
Diluted EPS | -$0.02 |
News
See moreYahoo Finance • 15 days ago
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
Yahoo Finance • 2 months ago
Here are the major earnings before the open Thursday
Yahoo Finance • 2 months ago
Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights
Yahoo Finance • 4 months ago
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. John P. Butler MBA |
CFO | Mr. Erik John Ostrowski M.B.A. |
Address | 245 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 194 |
